SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
CULVER CITY,Calif.,Feb. 14,2025-- Snail Games (Nasdaq: SNAL),a premier global developer and publisher of interactive digital entertainment,celebrates new milestones that are reshaping the ARK universe
XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie
DUBAI,UAE,Feb. 14,2025-- Wearing a "Tech Support"-printed T-shirt,Elon Musk virtually took to the stage on the final day of the World Governments Summit in a live discussion with H.E. Omar S
BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu
LambdaTest Partner Awards 2024 honors the top partners globally for their contributions to quality engineering and innovation.
SHENZHEN,China,Feb. 14,2025-- Omdia released the Omdia Universe: CloudOps,2025 report recently. In the report,Huawei was ranked No. 1 globally in CloudOps in terms of strategy and execution,and No. 2
SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
© OfficialAffairs
